Skip to main content
Professional Formal IVT

cardiac event adjudication committee

A multidisciplinary expert panel that reviews and classifies cardiac events in athletes to determine causality and appropriate medical management.

Full Definition

A cardiac event adjudication committee is a specialized multidisciplinary panel of experts responsible for the systematic review, classification, and determination of cardiac events occurring in athletic populations. These committees typically include sports cardiologists, electrophysiologists, pathologists, and other relevant specialists who review clinical data, diagnostic studies, and circumstances surrounding cardiac events to establish definitive diagnoses and causal relationships. The committee's role is crucial in distinguishing exercise-related cardiac events from coincidental occurrences, determining the appropriateness of return-to-play decisions, and contributing to epidemiological understanding of sports-related cardiac risks. Their adjudications often serve as the basis for policy decisions regarding athlete safety protocols and screening program modifications.

Usage

Usage note: Always use the full term in first reference; may abbreviate as 'adjudication committee' in subsequent uses within the same document.

In Context

  • "The cardiac event adjudication committee determined that the athlete's collapse was unrelated to underlying cardiac pathology." — Research study methodology
  • "All suspected cardiac events in the registry are reviewed by an independent cardiac event adjudication committee using standardized criteria." — Clinical trial protocol

Also known as

cardiac event review panel sports cardiac adjudication board

Contrasted with

individual clinical assessment single-physician evaluation

Don't confuse with

institutional review board medical advisory committee

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON